Utah Medical Products | UTMD - Equity Capital And Reserves


Utah Medical Products reported $118.25M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
AngioDynamics USD 185.87M 898K Feb/2025
Baxter International USD 6.13B 1.11B Dec/2025
Cerus USD 61.46M 6.04M Sep/2025
CONMED USD 1.03B 24.83M Dec/2025
Cooper Companies USD 8.36B 124.7M Dec/2025
General Electric Aerospace USD 18.9B 86M Dec/2025
Integra LifeSciences USD 1.04B 5.89M Dec/2025
J&J USD 78.47B 0 Sep/2025
Medtronic USD 48.86B 964M Sep/2025
Merit Medical Systems USD 1.58B 54.9M Dec/2025
OraSure Technologies USD 361.98M 18.74M Sep/2025
Rockwell Medical USD 30.41M 1.11M Jun/2025
STAAR Surgical USD 344.18M 9.6M Dec/2025
Stryker USD 21.78B 594M Sep/2025
Teleflex USD 3.12B 697.09M Dec/2025
Utah Medical Products USD 118.25M 719K Sep/2025
West Pharmaceutical Services USD 3.18B 124.5M Dec/2025